OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
Generic: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
Solco Healthcare USManufacturer
ORALRoute
OLMESARTAN MEDOXOMILActive Substance
2017-04-24Original Approval
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE is FDA application ANDA207804, sponsored by PRINSTON. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FATIGUE
17 reports
2
DIARRHOEA
15 reports
3
ASTHENIA
14 reports
4
DIZZINESS
12 reports
5
DRUG INEFFECTIVE
10 reports
6
NAUSEA
10 reports
7
VOMITING
9 reports
8
HEADACHE
8 reports
9
OFF LABEL USE
8 reports
10
PRODUCT DOSE OMISSION ISSUE
8 reports